Catalyst Funds Management Pty »

Arrowhead Pharmaceuticals shares owned by Catalyst Funds Management Pty

Quarter-by-quarter ownership of Arrowhead Pharmaceuticals (ARWR) shares owned by Catalyst Funds Management Pty from 13F filings

Historical chart of Catalyst Funds Management Pty investment in Arrowhead Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Arrowhead Pharmaceuticals held by Catalyst Funds Management Pty consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Arrowhead Pharmaceuticals by Catalyst Funds Management Pty

Quarter filed Position value Share count Share price at filing
2026-06-30 $9.6M 118k 81.51

More positions owned by Catalyst Funds Management Pty

Apple Ordinary Shares (AAPL)
Bloom Energy Corp Ordinary Shares - Class A (BE)
Intel Corp. Ordinary Shares (INTC)
Microsoft Corporation Ordinary Shares (MSFT)
Credo Technology Group Holding Ordinary Shares (CRDO)
Lilly Ordinary Shares (LLY)
Vertiv Holdings Ordinary Shares - Class A (VRT)
Sterling Infrastructure Ordinary Shares (STRL)
Amazon.com Ordinary Shares (AMZN)
Qualcomm Ordinary Shares (QCOM)
Salesforce Ordinary Shares (CRM)
IonQ Ordinary Shares (IONQ)
Nextpower Ordinary Shares - Class A (NXT)
TTM Technologies Ordinary Shares (TTMI)
Fabrinet Ordinary Shares (FN)

View all positions for Catalyst Funds Management Pty

Top funds holding Arrowhead Pharmaceuticals

BlackRock
venBio Select Advisor
FMR
State Street Corporation
Vanguard Portfolio Management
Vanguard Capital Management
Norges Bank Investment Management
Invesco
Geode Capital Management
Fred Alger Management
Baker Bros. Advisors
Susquehanna International
Siren
Vestal Point Capital
Henderson Group

View all funds holding Arrowhead Pharmaceuticals